Home / Biosimilars

Biosimilars

News

Adalimumab biosimilar Idacio launched in Germany posted 17/05/2019

Fresenius Kabi, one of the independently operated business segments of global healthcare group Fresenius, announced on 3 May...

EMA approval for pegfilgrastim biosimilar Grasustek posted 10/05/2019

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 26 April 2019 that i...

FDA approves etanercept biosimilar Eticovo posted 08/05/2019

Korean biosimilars maker Samsung Bioepis (Samsung and Biogen’s joint venture) announced on 25 April 2019 that it had received...

Intas launches trastuzumab similar biologic in India at 65% discount posted 08/05/2019

India-based generics maker Intas Pharmaceuticals (Intas) announced on 9 April 2019 the launch of its product Eleftha, a ‘simi...

Rituximab biosimilar Truxima approved in Canada posted 19/04/2019

Teva Canada Innovation, a subsidiary of Teva Pharmaceutical Industries, announced on 10 April 2019 that Health Canada had app...

 

Research

ASCO/ASH give recommendations for biosimilar ESAs posted 20/05/2019

Recommendations for biosimilar erythropoiesis-stimulating agents (ESAs) in the management of cancer-associated anaemia have b...

Biosimilars education still needed for US and EU clinicians posted 15/05/2019

A review of the literature has concluded that healthcare providers are still cautious when it comes to biosimilars and that c...

Pharmacokinetic assessment of biosimilar therapeutic monoclonal antibodies posted 15/05/2019

Comparison of the clinical pharmacokinetic (PK) profile of a biosimilar with that of the reference product is an important st...

ASCO/ASH update ESA recommendations posted 15/05/2019

The American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH) have updated their recommendati...

Biosimilar comparability assessment posted 15/05/2019

In a recent review, Ishii-Watabe and Kuwabara summarize the principles of biosimilar development and outline key consideratio...

 

General

Canadian organizations collaborate to improve biosimilar adoption in cancer and inflammatory rheumatic and bowel disease posted 20/05/2019

With a number of biosimilars expected to launch in Canada in 2019 and beyond, Canadian organizations are collaborating to imp...

Patient and provider views on biosimilars to treat breast cancer posted 10/05/2019

A Canadian breast cancer advocacy group collected insights from patients and medical oncologists regarding the use of biosimi...

FDA to hold public meeting on access to affordable insulin posted 26/04/2019

The US Food and Drug Administration (FDA) is seeking input on the challenges and opportunities the agency should consider as...

Eli Lilly to introduce half-price authorized insulin biosimilar in US posted 19/04/2019

With high drug prices increasingly coming into the spotlight, Eli Lilly has announced that it will introduce a lower-priced a...

Biocad advancing its non-originator biologicals in Russia posted 15/04/2019

Russian biotechnology company Biocad has started an eculizumab study and has also registered its non-originator biological (B...